This technology involves the development of a spray designed to enhance immunity and combat inflammation while effectively inhibiting respiratory viruses, including H1N1, RSV, and COVID-19, as demonstrated in pre-clinical testing. The product is a result of a comprehensive process, starting from the cultivation of specific target plants for extracting key compounds, leading to formulation development, and culminating in non-clinical and clinical studies. The primary problem addressed by this technology is the need for effective virus prevention and inflammation reduction, particularly among individuals interested in maintaining their health and preventing viral infections, such as reducing susceptibility to respiratory diseases.
The target audience for this technology includes individuals who are interested in proactive health maintenance and seek to protect themselves from viral infections while mitigating inflammation-related health issues. This IP addresses a significant need in the marketplace by offering a proactive solution for individuals looking to bolster their immune systems and reduce the risk of viral infections, which has become especially pertinent in the context of the COVID-19 pandemic. Furthermore, the technology's focus on inflammation reduction aligns with the growing awareness of the importance of immune system support and overall health optimization, making it a relevant and valuable innovation for health-conscious consumers.
The technology owner is seeking for licensing and R&D collaborations into other various applications.
The technical features and specifications of this innovative virus prevention and immune enhancement spray can be described as follows:
With its focus on virus prevention, immune enhancement, and inflammation reduction, this technology has a wide range of potential applications across several industries such as:
The heightened awareness of immune health and viral protection due to COVID-19 pandemic, coupled with an ageing population growing demand for immune support and inflammation- reducing products, underscores the relevance of this technology. The trend of health-conscious consumers actively seeking well-being solutions further enhances its market appeal. While the exact market size may vary based on location and specific applications, these factors collectively suggest a significant and expanding market for this technology, contingent on effective marketing, distribution, and adherence to regulatory standards.
Antiviral Properties: This technology has antiviral properties against various viruses, such as influenza H1N1, COVID-19, as well as RSV. Broad-spectrum antiviral efficacy achieved using natural and sustainable ingredients.
Anti-inflammatory Effects: Inflammation plays a pivotal role in the body's immune response. This technology has demonstrated anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines. This can potentially modulate the immune response and reduce the severity of diseases like allergies and asthma.
Mast Cell Stabilization: This technology has been shown to stabilize mast cells and reduce the release of histamine, which is implicated in allergic responses.
Improved Pharmacokinetics: Natural extracts usually exhibits low pharmacokinetics, the technology encompass processes to enhance the pharmacokinetics of these extracts, making them more bioavailable and effective. Besides the oral spray, a nasal spray formulation is in development.
Compatibility: The extracts are tailored to be compatible with water-based products, further broadening their potential applications.
The technology presents itself as a versatile, science-backed, and holistic approach to wellness. Unlike many single-purpose application, this technology offers a well-rounded and forward-thinking solution that addresses multiple facets of health, setting it apart as a transformative and indispensable innovation in the field.